ALOKA unveils new flagship ProSound F75 model to European market at ISUOG 2010
New system matches ‘sound velocity’ to FIT specific organ and tissue types, giving far higher image resolutions
Zug, Switzerland – 08 October 2010 - ALOKA Holding
Europe AG, is unveiling its new flagship model, the ProSound F75, at the
20th ISUOG World Congress in Prague, Czech Republic.
The F75 system has been designed with the new ALOKA ‘FIT’ ethos (Facilitated workflow; Investment return; True
diagnostics) at its heart and each machine can be tailored to the needs
of any clinician (with over 45 kinds of user presets). This not only
simplifies the process for the clinician, but also vastly reduces
patient dependency and the time taken to conduct each assessment.
What’s more, the intelligent ‘sound velocity’ adjustment alters the
frequency at which the signal is passed through tissue enabling the
system to be always operating at the optimal speed for different tissue
The system has bespoke settings for Obstetrics and Gynecology
assessments (a patient’s age, weight and stage in pregnancy), and
includes a new feature to simultaneously display stored and real-time
images, which is a highly useful clinical tool during follow-up
Prof. Giuseppe Rizzo a ProSound F75 user from the department of
obstetrics and gynecology at the San Giovanni Calibita Hospital
commented: “I was greatly impressed by the quality of this new
ultrasound system from ALOKA, the ProSound F75. This premium ultrasound
unit is exceptionally ergonomic and compact, and clinicians with no
prior experience can be trained on all necessary functions for scanning
extremely quickly and without any difficulties. B-Mode imaging is
excellent in every condition, gestational age and type of patient, with
extremely detailed fetal heart examinations - even in the early weeks.
In addition, the eFlow+ technique is also superb and provides an
excellent sensitivity, together with a high resolution, that ensures
diagnostic confidence in first trimester fetal heart examinations.”
THE ALOKA ‘FIT’ principles:
F: Facilitated workflow
The ProSound F75 acknowledges the needs of performing examinations in a
natural posture without stress or discomfort. The monitor and operation
panel have a wide range of movement, which enables reduction of the
operator's muscle load up to 20%. Another factor is automation of
operation to make examinations flow smoother. The ProSound F75 allows
simple operation so the operator can concentrate on the examination in
I: Investment return
The ProSound F75 covers numerous applications in one console, with its
wide variety of probes, measurement/report package, and many other
factors. Affordable cost of ownership is guaranteed due to the reliable
system design and easy-to-upgrade software. With simple and intuitive
operation, new users can easily learn to operate the system.
T: True diagnostics
By combining all of our cutting-edge technologies, the ProSound F75
performs high spatial resolution. The combination of the CPWG+ (compound
pulse wave generator, the new front-end processor) and Full Aperture
Apodization (uses all transducer elements of a probe) perfects focus
throughout the entire image. This technology will enhance the efficiency
of examinations, and will benefit both patients and examiners.
The ProSound F75 will be available for shipment in Europe from November
ALOKA CO., LTD is a leading health and scientific company operating in
three core areas: Medical Electronic Systems – diagnostic ultrasound;
General Analytical Instruments – radiation measurement; and Clinical
Laboratory Systems – specimen preprocessing. It has been the world’s
leading pioneer of ultrasound systems for the medical and health science
industries for nearly 60 years, providing ultrasound solutions to the
Obstetrics/Gynecology, General Imaging, Internal Medicine,
Cardiovascular, Surgical and Endoscopic Ultrasound fields.
ALOKA’s worldwide headquarters are located in Tokyo, Japan, and with 40
domestic and 16 overseas business establishments, including
subsidiaries; ALOKA exports its products to more than 150 countries.
With its commitment to “Illuminate the Change; See the unseen”, ALOKA
is dedicated to excellence providing the systems to advance prognosis,
prediction and prevention, ensuring the best quality of life for
patients and society.